Share on LinkedInShare on LinkedIn

ARTICLE · 02 APRIL 2020

Antitrust & COVID-19

Cleary Gottlieb Steen & Hamilton LLP
Explore more from Cleary Gottlieb Steen & Hamilton LLP

The COVID-19 pandemic presents unprecedented issues for businesses and we recognize that antitrust is unlikely to be your most important concern at this time.

United StatesCoronavirus (COVID-19)

The COVID-19 pandemic presents unprecedented issues for businesses and we recognize that antitrust is unlikely to be your most important concern at this time.

However, some forethought may mitigate risk of future exposure, and position your business as well as possible in this dynamic environment.

This memo supplements the materials available on our Resource Center, and provides an initial overview of antitrust-related issues that businesses may confront in the coming days, weeks, and months.  Some are specific to this crisis; others may be more analogous to previous times of economic difficulty.

  • Antitrust.  Dealing with the outbreak could raise various antitrust issues in the near term: short-term shortages of certain products could lead to allegations of price gouging or excessive pricing, or the discriminatory allocation of scarce supplies; rivals may want to cooperate on medical developments or to ensure the ongoing supply of important goods; and companies

We operate a free-to-view policy, asking only that you register in order to read all of our content. Please login or register to view the rest of this article.

The content of this article is intended to provide a general guide to the subject matter. Specialist advice should be sought about your specific circumstances.

See more popular content from